Publications
144
Citations
2,280
Est. group size
~1
Recurring co-author estimate
Active years
22
Publishing since 2005
Ashay D. Bhatwadekar studies diabetic retinopathy, an eye disease caused by diabetes that damages the retina and can lead to vision loss. The research explores how factors such as circadian rhythms (the body's internal clock), gene regulation, blood vessel growth, and metabolism contribute to retinal damage, and tests potential drug treatments in mouse and cell models. Some work also uses artificial intelligence to detect the disease from retinal images.
Publication activity has varied year to year, peaking around 2020 and settling to roughly 5 papers per year in recent years, indicating a fairly steady output.
Generated by claude-opus-4-8 from public bibliographic data · Jul 9, 2026
Current awards run through April 2030 — about 4 years of funding on record from today. Awards are often renewed, so this is what is currently public, not a forecast.
Short-Term Training in Ophthalmology Research for Medical Students
Orexinergic system and Circadian Rhythm Disruption
miR-92a as a biomarker of diabetic retinopathy
1 earlier award
- NIH R01EY027779Sep 2017 – Jun 2024 · $382k awarded
Circadian Rhythms in Müller Cell Dysfunction
Matched to public NIH RePORTER and NSF records by name and institution. Awards from other agencies are not shown, and a match is not always found — this list may be incomplete.
Typically publishes in teams of ~5 · 23% small-team papers (≤3 authors) · across 29 venues
- High-fat Western diet induces retinal and metabolic alterations in APOE3 and APOE4 knock-in mice
Scientific Reports · 2026
- Suvorexant protects from ocular complications of diabetes in db/db mice
BMJ Open Diabetes Research & Care · 2026
- Investigating the Roles of miR-148a-3p and miR-126-5p in Mouse and in vitro Models of Diabetic Retinopathy
Proceedings of IMPRS · 2026
- Retinal manifestations and their diagnostic significance in Alzheimer's disease
Journal of Alzheimer s Disease Reports · 2025
- Precision Medicine for Diabetic Retinopathy: Integrating Genetics, Biomarkers, Lifestyle, and AI
Genes · 2025
- Orexin Blockers’ Role in Glucose Homeostasis and Diabetic Retinopathy
Proceedings of IMPRS · 2025
- Transcriptomic Profile of Lin−Sca1+c-kit (LSK) cells in db/db mice with long-standing diabetes
BMC Genomics · 2024
- Transcriptomic Profile of Lin - Sca1 + c-kit (LSK) cells in db/db mice with long-standing diabetes
bioRxiv (Cold Spring Harbor Laboratory) · 2024
- Global mapping of BMAL1 protein-DNA interactions in human retinal Müller cells.
PubMed · 2024
- Circadian Rhythm Types in Individuals with Diabetic Macular Edema
Proceedings of IMPRS · 2023
- miR-92a and integrin expression in fibrovascular membranes in proliferative diabetic retinopathy
Frontiers in Ophthalmology · 2023
- Further Characterization of Multi-Organ DEARE and Protection by 16,16 Dimethyl Prostaglandin E2 in a Mouse Model of the Hematopoietic Acute Radiation Syndrome
Radiation Research · 2023
- Circadian rhythm disruption results in visual dysfunction
FASEB BioAdvances · 2022
- Senolytics in the treatment of diabetic retinopathy
Frontiers in Pharmacology · 2022
- Dapagliflozin protects neural and vascular dysfunction of the retina in diabetes
BMJ Open Diabetes Research & Care · 2022
- Investigative Ophthalmology & Visual Science×17
- Proceedings of IMPRS×7
- bioRxiv (Cold Spring Harbor Laboratory)×5
- PMC×4
- Expert Opinion on Investigational Drugs×3
- Thomas W. Gardner
Medicine · University of Michigan
- Todd Peabody
Medicine · Indiana University
- Mohammad Othman
Medicine · University of Michigan
- David M. Wu
Medicine · University of Michigan
- Emily Fletcher
Medicine · Purdue University West Lafayette
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Sep 1, 2026.
Claim or correct this profile